DERMAPHARM HOLDING SE (DMP.DE) Stock Earnings & Estimates
Europe - FRA:DMP - DE000A2GS5D8 - Common Stock
33 EUR
-0.25 (-0.75%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.025B 8.68% | 1.135B 10.79% | 1.181B 4.00% | 1.193B 1.04% | 1.24B 3.94% | 1.287B 3.79% | 1.352B 5.05% | 1.397B 3.33% | 1.454B 4.08% | 1.462B 0.55% | 1.513B 3.49% | |
| EBITDA YoY % growth | 378.35M 11.04% | 302.764M -19.98% | 314.578M 3.90% | 330.12M 4.94% | 347.22M 5.18% | 364.04M 4.84% | 357.68M -1.75% | 307.09M -14.14% | 437.74M 42.54% | N/A | N/A | |
| EBIT YoY % growth | 283.441M -4.07% | 200.992M -29.09% | 227.793M 13.33% | 236.66M 3.89% | 252.3M 6.61% | 269.55M 6.84% | 295.78M 9.73% | 285.83M -3.36% | 295.83M 3.50% | 299.26M 1.16% | 309.74M 3.50% | |
| Operating Margin | 27.66% | 17.70% | 19.29% | 19.84% | 20.35% | 20.94% | 21.88% | 20.46% | 20.35% | 20.47% | 20.47% | |
| EPS YoY % growth | N/A -9.92% | N/A -36.10% | N/A -8.62% | 2.31 13.00% | 2.56 10.92% | 2.80 9.32% | 3.54 26.19% | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 1.15 173.81% | 0.99 | 0.16 | 16.19% |
| Q2 2021 Q2Q % growth | 0.74 236.36% | % | ||
| Q1 2021 Q2Q % growth | 0.67 | 0.60 | 0.07 | 12.43% |
| Q4 2020 Q2Q % growth | -66.45% | 0.52 | % | |
| Q3 2020 Q2Q % growth | 0.42 16.67% | 0.43 | -0.01 | -3.29% |
| Q2 2020 Q2Q % growth | 0.22 -42.11% | 0.38 | -0.16 | -42.68% |
| Q3 2019 Q2Q % growth | 0.36 | 0.44 | -0.08 | -18.99% |
| Q2 2019 Q2Q % growth | 0.38 | 0.44 | -0.06 | -14.49% |
| Q1 2019 Q2Q % growth | 0.36 | 0.44 | -0.08 | -18.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 272.146M -2.74% | % | ||
| Q1 2025 Q2Q % growth | 302.396M 1.24% | % | ||
| Q4 2024 Q2Q % growth | 290.67M 8.14% | % | ||
| Q3 2024 Q2Q % growth | 311.602M 9.54% | % | ||
| Q2 2024 Q2Q % growth | 279.802M 6.40% | % | ||
| Q1 2024 Q2Q % growth | 298.691M -6.40% | % | ||
| Q4 2023 Q2Q % growth | 268.798M -7.48% | % | ||
| Q3 2023 Q2Q % growth | 284.466M 8.10% | % | ||
| Q2 2023 Q2Q % growth | 262.969M 9.81% | % | ||
| Q1 2023 Q2Q % growth | 319.118M 37.76% | % | ||
| Q4 2022 Q2Q % growth | 290.517M 6.53% | % | ||
| Q3 2022 Q2Q % growth | 263.139M 8.54% | % | ||
| Q2 2022 Q2Q % growth | 239.479M 11.11% | % | ||
| Q1 2022 Q2Q % growth | 231.641M 9.16% | % | ||
| Q4 2021 Q2Q % growth | 272.716M 25.88% | % | ||
| Q3 2021 Q2Q % growth | 242.446M 21.85% | 248.76M | -6.314M | -2.54% |
| Q2 2021 Q2Q % growth | 215.538M 16.05% | 216.65M | -1.112M | -0.51% |
| Q1 2021 Q2Q % growth | 212.211M 10.26% | 219.51M | -7.299M | -3.33% |
| Q4 2020 Q2Q % growth | 216.655M 18.20% | 213.35M | 3.305M | 1.55% |
| Q3 2020 Q2Q % growth | 198.978M 7.90% | 205.03M | -6.052M | -2.95% |
| Q2 2020 Q2Q % growth | 185.727M 9.50% | 189.22M | -3.493M | -1.85% |
| Q1 2020 Q2Q % growth | 192.469M 17.68% | % | ||
| Q4 2019 Q2Q % growth | 183.302M | 168.42M | 14.882M | 8.84% |
| Q3 2019 Q2Q % growth | 184.406M | 172.51M | 11.896M | 6.90% |
| Q2 2019 Q2Q % growth | 169.619M | 171.7M | -2.081M | -1.21% |
| Q1 2019 Q2Q % growth | 163.553M | 163.62M | -67K | -0.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -1.37% |
| Revenue | N/A | N/A | 0% | -1% |